<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nmp</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Sklifosovsky Journal "Emergency Medical Care"</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2223-9022</issn><issn pub-type="epub">2541-8017</issn><publisher><publisher-name>“N.V. Sklifosovsky Research Institute for Emergency Medicine”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.23934/2223-9022-2019-8-3-315-319</article-id><article-id custom-type="elpub" pub-id-type="custom">nmp-692</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНО-ОРГАНИЗАЦИОННЫЕ ПРОБЛЕМЫ НЕОТЛОЖНОЙ МЕДИЦИНСКОЙ ПОМОЩИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC AND ORGANIZATIONAL PROBLEMS OF EMERGENCY MEDICAL CARE</subject></subj-group></article-categories><title-group><article-title>Структура и лабораторная диагностика немедицинского потребления современных синтетических наркотических средств</article-title><trans-title-group xml:lang="en"><trans-title>Structure and Laboratory Diagnostics of Non-medical Consumption of Modern Synthetic Drugs</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8636-9858</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балабанова</surname><given-names>О. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Balabanova</surname><given-names>O. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Балабанова Ольга Леонидовна - врач химико-токсикологической лаборатории государственного бюджетного учреждения здравоохранения</p><p>192242, Санкт-Петербург, Будапештская ул., д. 3, лит. А </p></bio><bio xml:lang="en"><p>Olga L. Balabanova - Physician of Chemical and Toxicologic Laboratory</p><p>Budapeshtskaya St., 3A, Saint Petersburg 192243</p></bio><email xlink:type="simple">o.l.ya@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3256-2609</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шилов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shilov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шилов Виктор Васильевич - заведующий кафедрой токсикологии, экстремальной и водолазной медицины</p><p>195067, Санкт-Петербург, Пискаревский пр., д. 47, пав. 26 </p></bio><bio xml:lang="en"><p>Viktor V. Shilov - Head of thr Department of Toxicology, Extreme and Diving Medicine</p><p>Piskarevsky proezd, 47, Saint Petersburg 195067</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8672-2906</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лодягин</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Lodyagin</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лодягин Алексей Николаевич - руководитель отдела клинической токсикологии ГБУ «СПб НИИ СП им. И.И. Джанелидзе»</p><p>195067, Санкт-Петербург, Пискаревский пр., д. 47, пав. 26 </p></bio><bio xml:lang="en"><p>Aleksey N. Lodyagin - Head of the Department of Clinical Toxicology, I.I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medical Aid</p><p>Piskarevsky proezd, 47, Saint Petersburg 195067</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7466-6804</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глушков</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Glushkov</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Глушков Сергей Иванович - ведущий научный сотрудник</p><p>Химико-токсикологическая лаборатория</p><p>192242, Санкт-Петербург, Будапештская ул., д. 3, лит. А </p></bio><bio xml:lang="en"><p>Sergey I. Glushkov - Leading Researcher</p><p>Budapeshtskaya St., 3A, Saint Petersburg 192243</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ГБУ «Санкт-Петербургский научно-исследовательский институт скорой помощи им. И.И. Джанелидзе»<country>Россия</country></aff><aff xml:lang="en">I.I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medical Aid<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» МЗ РФ<country>Россия</country></aff><aff xml:lang="en">I.I. Mechnikov Northwestern State Medical University of the Ministry of Health of Russian Federation<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>05</day><month>11</month><year>2019</year></pub-date><volume>8</volume><issue>3</issue><fpage>315</fpage><lpage>319</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Балабанова О.Л., Шилов В.В., Лодягин А.Н., Глушков С.И., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Балабанова О.Л., Шилов В.В., Лодягин А.Н., Глушков С.И.</copyright-holder><copyright-holder xml:lang="en">Balabanova O.L., Shilov V.V., Lodyagin A.N., Glushkov S.I.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.jnmp.ru/jour/article/view/692">https://www.jnmp.ru/jour/article/view/692</self-uri><abstract><p>Во всем мире отмечается появление новых синтетических наркотических средств, что вызывает значительные трудности в оказании помощи больным для врачей-токсикологов, реаниматологов, наркологов и врачей клинической лабораторной диагностики, связанные с отсутствием доступных данных с описанием клинической картины отравлений подобными соединениями и необходимых методов лабораторной диагностики. Клиническая картина наркотического опьянения или отравления новыми синтетическими веществами в большинстве случаев отличается от симптомов, вызываемых ранее известными наркотическими средствами, такими как кокаин, опиаты. Поэтому химико-токсикологическое исследование является одним из важных аспектов для установления факта опьянения или отравления.</p></abstract><trans-abstract xml:lang="en"><p>The emergence of new synthetic narcotic drugs is noted all over the world. The situation causes significant difficulties for toxicologists, resuscitators, narcologists, and clinical laboratory diagnostics doctors due to the lack of available data on the clinical picture of poisoning by these compounds and laboratory diagnostic methods. In most cases, the clinical picture of drug intoxication or poisoning with new synthetic substances differs from the symptoms caused by previously known drugs, such as cocaine or opiates. Therefore, chemical toxicological research is one of the important aspects for establishing the fact of intoxication or poisoning.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>наркотическое опьянение</kwd><kwd>синтетические каннабиноиды</kwd><kwd>производные фентанила</kwd><kwd>катиноны</kwd><kwd>химико-токсикологические исследования</kwd></kwd-group><kwd-group xml:lang="en"><kwd>drug intoxication</kwd><kwd>synthetic cannabinoids</kwd><kwd>fentanyl derivatives</kwd><kwd>cathinones</kwd><kwd>chemical and toxicological studies</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">EMCDDA – 2015. European drug report – 2015: trends and developments. URL: http://www.emcdda.europa.eu/attachemcnts.cfm/att_239505_EN_TDAT15001_ENN.pdf [Дата обращения 14 августа 2019 г.]</mixed-citation><mixed-citation xml:lang="en">EMCDDA – 2015. European drug report 2015: trends and developments. Available at: http://www.emcdda.europa.eu/attachemcnts.cfm/att_239505_EN_TDAT15001_ENN.pdf[Accessed Aug 14, 2019]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">UNODC Word drug report 2015. URL: http://www.unodc.org/documents/wdr2015/WDR15_ExSum.pdf [Дата обращения 14 августа 2019 г.]</mixed-citation><mixed-citation xml:lang="en">UNODC Word drug report 2015. Available at: http://www.unodc.org/documents/wdr2015/WDR15_ExSum.pdf [Accessed Aug 14, 2019]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cottencin O, Rolland B, Karila L. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature. Curr Pharm Des. 2014;20(25):4106–4111. PMID: 24001292 https://doi.org/10.2174/13816128113199990622</mixed-citation><mixed-citation xml:lang="en">Cottencin O, Rolland B, Karila L. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature. Curr Pharm Des. 2014;20(25):4106–4111. PMID: 24001292 https://doi.org/10.2174/13816128113199990622</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zawilska JB, Wojcieszak J. Spice/K2 drugs-more than innocent substitutes for marijuana. Int J Neuropsychopharmacol. 2014;17(3):509– 525. PMID: 24169044 https://doi.org/10.1017/S1461145713001247</mixed-citation><mixed-citation xml:lang="en">Zawilska JB, Wojcieszak J. Spice/K2 drugs-more than innocent substitutes for marijuana. Int J Neuropsychopharmacol. 2014;17(3):509– 525. PMID: 24169044 https://doi.org/10.1017/S1461145713001247</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Huffman JW, Szklennik PV, Almond A, Bushell K, Selley DE, He H, et al. l-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorg Med Chem Lett. 2005;15(18):4110–4113. PMID: 16005223 https://doi.org/10.1016/j.bmcl.2005.06.008</mixed-citation><mixed-citation xml:lang="en">Huffman JW, Szklennik PV, Almond A, Bushell K, Selley DE, He H, et al. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorg Med Chem Lett. 2005;15(18):4110–4113. PMID: 16005223 https://doi.org/10.1016/j.bmcl.2005.06.008</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Huffman JW, Zengin G, Wu MJ, Lu J, Hynd G, Bushell K, et al. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl) indoles at the cannabinoid CBl and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists. Bioorg Med Chem. 2005;13(1):89–112. PMID: 15582455 https://doi.org/10.1016/j.bmc.2004.09.050</mixed-citation><mixed-citation xml:lang="en">Huffman JW, Zengin G, Wu MJ, Lu J, Hynd G, Bushell K, et al. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl) indoles at the cannabinoid CBl and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists. Bioorg Med Chem. 2005;13(1):89–112. PMID: 15582455 https://doi.org/10.1016/j.bmc.2004.09.050</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wiley JL, Marusich JA, Lefever TW, Grabenauer M, Moore KN, Thomas BF. Cannabinoids in disguise: A9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles. Neuropharmacology. 2013;75:145–154. PMID: 23916483 https://doi.org/10.1016/j.neuropharm.2013.07.022</mixed-citation><mixed-citation xml:lang="en">Wiley JL, Marusich JA, Lefever TW, Grabenauer M, Moore KN, Thomas BF. Cannabinoids in disguise: A9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles. Neuropharmacology. 2013;75:145–154. PMID: 23916483 https://doi.org/10.1016/j.neuropharm.2013.07.022</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">British Patent 403 GB927475 Wander A. a-Pyrrolidinovalerophenones; Bern, Switzerland; 1963.</mixed-citation><mixed-citation xml:lang="en">Wander A. a-Pyrrolidinovalerophenones; British Patent 403 GB927475; Bern, Switzerland; 1963.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">European Monitoring Centre for Drugs and Drug Addiction. EMCDDAEuropol. Report on the risk assessment of 1-phenyl-2-(pyrrolidin1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP), in the framework of the Council Decision on new psychoactive substances – 2016. Availble at: http://www.emcdda.europa.eu/system/files/publications/2934/TDAK16001ENN.pdf [Accessed Aug 14, 2019]</mixed-citation><mixed-citation xml:lang="en">European Monitoring Centre for Drugs and Drug Addiction. EMCDDAEuropol. Report on the risk assessment of 1-phenyl-2-(pyrrolidin1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP), in the framework of the Council Decision on new psychoactive substances – 2016. Availble at: http://www.emcdda.europa.eu/system/files/publications/2934/TDAK16001ENN.pdf [Accessed Aug 14, 2019]</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zawilska JB, Wojcieszak J. a-Pyrrolidinophenones: a new wave of designer cathinones. Forensic Toxicology. 2017;35(2):201–216. https://doi.org/10.1007/s11419-016-0353-6</mixed-citation><mixed-citation xml:lang="en">Zawilska JB, Wojcieszak J. a-Pyrrolidinophenones: a new wave of designer cathinones. Forensic Toxicology. 2017;35(2):201–216. https://doi.org/10.1007/s11419-016-0353-6</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Об утверждении перечня наркотических средств, психотропных веществ и их прекурсоров, подлежащих контролю в Российской Федерации. Постановление Правительства Российской Федерации № 681 от 30.06.1998 г. URL: http://base.garant.ru/12112176/ [Дата обращения: 25.03.2019].</mixed-citation><mixed-citation xml:lang="en">Ob utverzhdenii perechnya narkoticheskikh sredstv, psikhotropnykh veshchestv i ikh prekursorov, podlezhashchikh kontrolyu v Rossiyskoy Federatsii. Postanovlenie Pravitel’stva Rossiyskoy Federatsii No 681 ot 30.06.1998 g. Available at: http://base.garant.ru/12112176/ [Accessed Aug 14, 2019]. (in</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
